Cancer

g-incpm staff

Working Together for Personalized Medicine

21.08.2016

Cancer, Personalized Medicine, Systems Biology, Disease, Drugs & Diagnostics, Genetics, Bioinformatics and Computational Biology, Diagnostic Techniques and Drugs

Meet the unique team of experts at the Nancy and Stephen Grand Israel National Center for Personalized Medicine

Varda Rotter and Moshe Oren

Reeducating Renegade p53

15.08.2016

Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

Mutated proteins that abet cancer growth can be turned against the cancer

Zebrafish blood vessels

Straight to the Gut

16.06.2016

Biochemistry, Cancer, Stem Cells, Molecular and Cell Biology, Evolution and Development

Stem cells must get oriented before taking on new properties

YEDA

One Patent, Three Drugs

16.03.2016

Cancer, Immunology, Yeda Technology Transfer, Diagnostic Techniques and Drugs

Portrazza is approved to by the US FDA to treat lung cancer

Efrat Dvash and Prof. Menachem Rubinstein

Discovery: A New Switch for Cell Death

16.02.2016

Biochemistry, Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics

Approved asthma drugs that block this switch show promise for managing common drug side effects

cancer-free prostate

Weizmann Institute Drug, TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico

04.01.2016

Life Sciences, Biochemistry, Cancer, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Biotechnology, Diagnostic Techniques and Drugs

Mutations shed light on cancer

Rare Disease is a Lens on Cancer

24.11.2015

Cancer, Personalized Medicine, Systems Biology, Molecular and Cell Biology, Disease, Drugs & Diagnostics

In children, lack of a protein causes a dangerous disease. Why do cancer cells suppress the same protein?

Bone marrow EPCR+ hematopoietic (blood-forming) stem cell in an anticoagulant niche

Blood-Forming Stem Cells' Balancing Act

03.11.2015

How does the body keep replenishing the supply of blood cells all our lives? Two pathways must work together

Metastatic melanoma cells. Image: NIH

Melanoma Mutations Mapped

08.07.2015

Cancer, Personalized Medicine, Molecular and Cell Biology, Disease, Drugs & Diagnostics

Scientists can now begin to make sense of the way a deadly cancer develops

PYK2 (red) and the cell-surface receptor (green) that triggers the cellular transition to a pro-metastatic state are found in the same membrane compartment (yellow) from which the transition signal is transmitted

Up Against a Triple Negative

08.07.2015

Cancer, Personalized Medicine, Molecular and Cell Biology, Disease, Drugs & Diagnostics

A signal stuck in the “on” position may hasten metastasis in certain breast cancers

Pages

Top Stories

Shedding Light on the Dark Hours

Credit: Coleen Murphy, Princeton University, Princeton, NJ

Cracking the Code of a Worm's Throat

“Eight Shining Examples of Excellence”

Burning Cancer’s Bridges

Press Releases

“Eight Shining Examples of Excellence”

The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions

A Discovery to Set Your Heart a-Knocking